Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.

Vukmirovic M, Herazo-Maya JD, Blackmon J, Skodric-Trifunovic V, Jovanovic D, Pavlovic S, Stojsic J, Zeljkovic V, Yan X, Homer R, Stefanovic B, Kaminski N.

BMC Pulm Med. 2017 Jan 12;17(1):15. doi: 10.1186/s12890-016-0356-4.

2.
3.

Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade.

Taube JM, Young GD, McMiller TL, Chen S, Salas JT, Pritchard TS, Xu H, Meeker AK, Fan J, Cheadle C, Berger AE, Pardoll DM, Topalian SL.

Clin Cancer Res. 2015 Sep 1;21(17):3969-76. doi: 10.1158/1078-0432.CCR-15-0244.

4.

Use of formalin-fixed paraffin-embedded samples for gene expression studies in breast cancer patients.

Musella V, Callari M, Di Buduo E, Scuro M, Dugo M, Miodini P, Bianchini G, Paolini B, Gianni L, Daidone MG, Cappelletti V.

PLoS One. 2015 Apr 6;10(4):e0123194. doi: 10.1371/journal.pone.0123194.

5.

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.

Duchnowska R, Jassem J, Goswami CP, Dundar M, Gökmen-Polar Y, Li L, Woditschka S, Biernat W, Sosińska-Mielcarek K, Czartoryska-Arłukowicz B, Radecka B, Tomasevic Z, Stępniak P, Wojdan K, Sledge GW Jr, Steeg PS, Badve S.

J Neurooncol. 2015 Mar;122(1):205-16. doi: 10.1007/s11060-014-1704-y.

6.

Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts.

Ng SB, Ohshima K, Selvarajan V, Huang G, Choo SN, Miyoshi H, Wang S, Chua HC, Yeoh AE, Quah TC, Koh LP, Tan PL, Chng WJ.

Orphanet J Rare Dis. 2014 Dec 5;9:165. doi: 10.1186/s13023-014-0165-x.

7.

Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.

Lee J, Sohn I, Do IG, Kim KM, Park SH, Park JO, Park YS, Lim HY, Sohn TS, Bae JM, Choi MG, Lim DH, Min BH, Lee JH, Rhee PL, Kim JJ, Choi DI, Tan IB, Das K, Tan P, Jung SH, Kang WK, Kim S.

PLoS One. 2014 Mar 5;9(3):e90133. doi: 10.1371/journal.pone.0090133.

8.

Transcriptome profiling of archived sectioned formalin-fixed paraffin-embedded (AS-FFPE) tissue for disease classification.

Kojima K, April C, Canasto-Chibuque C, Chen X, Deshmukh M, Venkatesh A, Tan PS, Kobayashi M, Kumada H, Fan JB, Hoshida Y.

PLoS One. 2014 Jan 30;9(1):e86961. doi: 10.1371/journal.pone.0086961.

9.

Accurate data processing improves the reliability of Affymetrix gene expression profiles from FFPE samples.

Callari M, Lembo A, Bianchini G, Musella V, Cappelletti V, Gianni L, Daidone MG, Provero P.

PLoS One. 2014 Jan 29;9(1):e86511. doi: 10.1371/journal.pone.0086511. Erratum in: PLoS One. 2014;9(4):e95814.

10.

An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples.

Thomas M, Poignée-Heger M, Weisser M, Wessner S, Belousov A.

J Clin Bioinforma. 2013 May 3;3(1):10. doi: 10.1186/2043-9113-3-10.

11.

Development and validation of a 32-gene prognostic index for prostate cancer progression.

Wu CL, Schroeder BE, Ma XJ, Cutie CJ, Wu S, Salunga R, Zhang Y, Kattan MW, Schnabel CA, Erlander MG, McDougal WS.

Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6121-6. doi: 10.1073/pnas.1215870110.

12.

Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples.

Mahoney DW, Therneau TM, Anderson SK, Jen J, Kocher JP, Reinholz MM, Perez EA, Eckel-Passow JE.

BMC Res Notes. 2013 Jan 30;6:33. doi: 10.1186/1756-0500-6-33.

13.

Imputing gene expression from selectively reduced probe sets.

Donner Y, Feng T, Benoist C, Koller D.

Nat Methods. 2012 Nov;9(11):1120-5. doi: 10.1038/nmeth.2207.

14.

Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.

Stolla M, Pelisek J, von Brühl ML, Schäfer A, Barocke V, Heider P, Lorenz M, Tirniceriu A, Steinhart A, Bauersachs J, Bray PF, Massberg S, Schulz C.

PLoS One. 2012;7(8):e43572. doi: 10.1371/journal.pone.0043572.

15.

Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes.

Rentoft M, Coates PJ, Laurell G, Nylander K.

PLoS One. 2012;7(4):e35276. doi: 10.1371/journal.pone.0035276.

16.

Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.

Fountzilas E, Markou K, Vlachtsis K, Nikolaou A, Arapantoni-Dadioti P, Ntoula E, Tassopoulos G, Bobos M, Konstantinopoulos P, Fountzilas G, Spentzos D.

Ann Oncol. 2012 Aug;23(8):2146-53. doi: 10.1093/annonc/mdr576.

17.
18.

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.

Abramovitz M, Barwick BG, Willis S, Young B, Catzavelos C, Li Z, Kodani M, Tang W, Bouzyk M, Moreno CS, Leyland-Jones B.

Br J Cancer. 2011 Nov 8;105(10):1574-81. doi: 10.1038/bjc.2011.355.

19.

Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer.

Armstrong K, Ahmad I, Kalna G, Tan SS, Edwards J, Robson CN, Leung HY.

Br J Cancer. 2011 Oct 25;105(9):1362-9. doi: 10.1038/bjc.2011.367.

20.

Genome-wide expression assay comparison across frozen and fixed postmortem brain tissue samples.

Chow ML, Li HR, Winn ME, April C, Barnes CC, Wynshaw-Boris A, Fan JB, Fu XD, Courchesne E, Schork NJ.

BMC Genomics. 2011 Sep 10;12:449. doi: 10.1186/1471-2164-12-449.

Items per page

Supplemental Content

Support Center